{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:00:19Z","timestamp":1790100019042,"version":"4.0.1"},"reference-count":48,"publisher":"IOP Publishing","issue":"21","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Phys. Med. Biol."],"published-print":{"date-parts":[[2020,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metastases from cutaneous squamous cell carcinoma (cSCC) occur in 2%\u20135% of cases. Surgery is the standard treatment, often combined with adjuvant radiotherapy. Concurrent carboplatin treatment with post-operative radiotherapy may be prescribed, although it has not shown benefit in recent clinical trials in high-risk cSCC patients. The novel high-Z nanoparticle thulium (III) oxide has been shown to enhance radiation dose delivery to brain tumors by specific uptake of these nanoparticles into the cancerous tissue. As the dose-enhancement capacity of thulium oxide nanoparticles following radiotherapy against metastatic cSCC cells is unknown, its efficacy as a radiosensitizer was evaluated, with and without carboplatin. Novel and validated human patient-derived cell lines of metastatic cSCC were used. The sensitivity of the cells to radiation was investigated using short-term proliferation assays as well as clonogenic survival as the radiobiological endpoint. Briefly, cells were irradiated with 125 kVp orthovoltage x-rays (0\u20136 Gy) with and without thulium oxide nanoparticles (99.9% trace metals basis; 50\n                    <jats:italic>\u00b5<\/jats:italic>\n                    g ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) or low dose carboplatin pre-sensitization. Cellular uptake of the nanoparticles was first confirmed by microscopy and found to have no impact on short-term cell survival for the cSCC cells, highlighting the biocompatibility of thulium oxide nanoparticles. Clonogenic cell survival assays confirmed radio-sensitization when exposed to thulium nanoparticles, with the cell sensitivity increasing by a factor of 1.24 (calculated at the 10% survival fraction) for the irradiated cSCC cells. The combination of carboplatin with thulium oxide nanoparticles with irradiation did not result in significant further reductions in survival compared to nanoparticles alone. This is the first study to provide\n                    <jats:italic>in vitro<\/jats:italic>\n                    data demonstrating the independent radiosensitization effect of high-Z nanoparticles against metastatic cSCC with or without carboplatin. Further preclinical investigations with radiotherapy plus high-Z nanoparticles for the management of metastatic cSCC are warranted.\n                  <\/jats:p>","DOI":"10.1088\/1361-6560\/abaa5d","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T18:15:41Z","timestamp":1596046541000},"page":"215018","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma"],"prefix":"10.1088","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-4609","authenticated-orcid":false,"given":"Jay","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-6801","authenticated-orcid":false,"given":"Elahe","family":"Minaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-2104","authenticated-orcid":false,"given":"Elette","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-6611","authenticated-orcid":false,"given":"Bruce G","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-3809","authenticated-orcid":false,"given":"Luke","family":"McAlary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1209-772X","authenticated-orcid":false,"given":"Jonathan R","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-313X","authenticated-orcid":false,"given":"Ruta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-6833","authenticated-orcid":false,"given":"Moeava","family":"Tehei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-7340","authenticated-orcid":false,"given":"Stephanie","family":"Corde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6671-029X","authenticated-orcid":false,"given":"Martin","family":"Carolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-9645","authenticated-orcid":false,"given":"Marie","family":"Ranson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"pmbabaa5dbib1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/ijms.3635","type":"journal-article","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"pmbabaa5dbib2","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","type":"journal-article","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"pmbabaa5dbib3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ppsc.201300276","type":"journal-article","article-title":"High-Z nanostructured ceramics in radiotherapy: first evidence of Ta2O5-induced dose enhancement on radioresistant cancer cells in an MV photon field","volume":"31","author":"Brown","year":"2014","journal-title":"Part. Part. Syst. Charact."},{"key":"pmbabaa5dbib4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/hed.23602","type":"journal-article","article-title":"Assessment of the new nodal classification for cutaneous squamous cell carcinoma and its effect on patient stratification","volume":"37","author":"Brunner","year":"2015","journal-title":"Head Neck"},{"key":"pmbabaa5dbib5","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1021\/acs.jmedchem.8b00838","type":"journal-article","article-title":"6-substituted hexamethylene amiloride (HMA) derivatives as potent and selective inhibitors of the human urokinase plasminogen activator for use in cancer","volume":"61","author":"Buckley","year":"2018","journal-title":"J. Med. Chem."},{"key":"pmbabaa5dbib6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.adengl.2018.03.018","type":"journal-article","article-title":"The value of adjuvant radiotherapy in cutaneous squamous cell carcinoma: a review","volume":"109","author":"Ca\u00f1ueto","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"pmbabaa5dbib7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.addr.2014.09.009","type":"journal-article","article-title":"Lessons from patient-derived xenografts for better in vitro modeling of human cancer","volume":"79","author":"Choi","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"pmbabaa5dbib8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1634\/theoncologist.2009-0210","type":"journal-article","article-title":"Treatment of unresectable and metastatic cutaneous squamous cell carcinoma","volume":"15","author":"Cranmer","year":"2010","journal-title":"Oncologist"},{"key":"pmbabaa5dbib9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MOO.0b013e328343e811","type":"journal-article","article-title":"Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck","volume":"19","author":"D\u2019Souza","year":"2011","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"pmbabaa5dbib10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/hed.23096","type":"journal-article","article-title":"Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases","volume":"35","author":"Ebrahimi","year":"2013","journal-title":"Head Neck"},{"key":"pmbabaa5dbib11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hed.21332","type":"journal-article","article-title":"Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary","volume":"32","author":"Ebrahimi","year":"2010","journal-title":"Head Neck"},{"key":"pmbabaa5dbib12","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ejmp.2016.10.024","type":"journal-article","article-title":"Optimizing dose enhancement with Ta2O5 nanoparticles for synchrotron microbeam activated radiation therapy","volume":"32","author":"Engels","year":"2016","journal-title":"Phys. Medica"},{"key":"pmbabaa5dbib13","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/aaca01","type":"journal-article","article-title":"Thulium oxide nanoparticles: a new candidate for image-guided radiotherapy","volume":"4","author":"Engels","year":"2018","journal-title":"Biomed. Phys. Eng. Express"},{"key":"pmbabaa5dbib14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ajpath.2011.05.012","type":"journal-article","article-title":"Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma","volume":"179","author":"Farshchian","year":"2011","journal-title":"Am. J. Pathol."},{"key":"pmbabaa5dbib15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-9027-6_8","type":"journal-article","article-title":"Quantitation of macropinocytosis in cancer cells","volume":"1928","author":"Galenkamp","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"pmbabaa5dbib16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12645-019-0057-9","type":"journal-article","article-title":"A comparison of the radiosensitisation ability of 22 different element metal oxide nanoparticles using clinical megavoltage x-rays","volume":"10","author":"Guerreiro","year":"2019","journal-title":"Cancer Nanotechnol."},{"key":"pmbabaa5dbib17","first-page":"1113","type":"journal-article","article-title":"The incidence of skin lesions in contrast media-induced chemical hypersensitivity","volume":"17","author":"Iordache","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"pmbabaa5dbib18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF03178355","type":"journal-article","article-title":"The use of the linear quadratic model in radiotherapy: a review","volume":"24","author":"Jones","year":"2001","journal-title":"Australas. Phys. Eng. Sci. Med."},{"key":"pmbabaa5dbib19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1445-2197.1992.tb07065.x","type":"journal-article","article-title":"Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastasis and their outcome","volume":"62","author":"Joseph","year":"1992","journal-title":"Aust. NZ J. Surg."},{"key":"pmbabaa5dbib20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1245\/s10434-011-1986-7","type":"journal-article","article-title":"Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread","volume":"19","author":"Kelder","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"pmbabaa5dbib21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12885-018-4720-z","type":"journal-article","article-title":"Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Cancer"},{"key":"pmbabaa5dbib22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/09553002.2017.1276309","type":"journal-article","article-title":"Gold nanoparticles as dose-enhancement agent for kilovoltage x-ray therapy of melanoma","volume":"93","author":"Kim","year":"2017","journal-title":"Int. J. Radiat. Biol."},{"key":"pmbabaa5dbib23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2144\/000112257","type":"journal-article","article-title":"CellProfiler: free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"Biotechniques"},{"key":"pmbabaa5dbib24","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.7150\/thno.22172","type":"journal-article","article-title":"Metal-based nanoenhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"pmbabaa5dbib25","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/aabab2","type":"journal-article","article-title":"Radiosensitisation enhancement effect of BrUdR and Ta 2 O 5 NSPs in combination with 5-fluorouracil antimetabolite in kilovoltage and megavoltage radiation","volume":"4","author":"Mcdonald","year":"2018","journal-title":"Biomed. Phys. Eng. Express"},{"key":"pmbabaa5dbib26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.radonc.2011.08.026","type":"journal-article","article-title":"Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy","volume":"100","author":"Mcmahon","year":"2011","journal-title":"Radiother. Oncol."},{"key":"pmbabaa5dbib27","doi-asserted-by":"publisher","DOI":"10.1038\/srep19442","type":"journal-article","article-title":"Imaging and radiation effects of gold nanoparticles in tumour cells","volume":"6","author":"Mcquaid","year":"2016","journal-title":"Sci. Rep."},{"key":"pmbabaa5dbib28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1805131","type":"journal-article","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"pmbabaa5dbib29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bjc.6603201","type":"journal-article","article-title":"HIF-1 and tumour radiosensitivity","volume":"95","author":"Moeller","year":"2006","journal-title":"Br. J. Cancer"},{"key":"pmbabaa5dbib30","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jid.2019.01.008","type":"journal-article","article-title":"Mutational patterns in metastatic cutaneous squamous cell carcinoma","volume":"139","author":"Mueller","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"pmbabaa5dbib31","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1088\/0031-9155\/60\/20\/7847","type":"journal-article","article-title":"Indirect radio-chemo-beta therapy: a targeted approach to increase biological efficiency of x-rays based on energy","volume":"60","author":"Oktaria","year":"2015","journal-title":"Phys. Med. Biol."},{"key":"pmbabaa5dbib32","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.2217\/nnm-2018-0171","type":"journal-article","article-title":"The role of thioredoxin reductase in gold nanoparticle radiosensitization effects","volume":"13","author":"Penninckx","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"key":"pmbabaa5dbib33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/cbr.2014.1680","type":"journal-article","article-title":"Thulium-170-labeled microparticles for local radiotherapy: preliminary studies","volume":"29","author":"Polyak","year":"2014","journal-title":"Cancer Biother. Radiopharm."},{"key":"pmbabaa5dbib34","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","type":"journal-article","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial","volume":"36","author":"Porceddu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"pmbabaa5dbib35","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1200\/JCO.2014.60.7333","type":"journal-article","article-title":"Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: current concepts, advances, and controversies","volume":"33","author":"Porceddu","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"pmbabaa5dbib36","first-page":"301","type":"journal-article","article-title":"Analysis of cell cycle by flow cytometry","volume":"281","author":"Pozarowski","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"pmbabaa5dbib37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jaad.2017.08.058","type":"journal-article","article-title":"Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"pmbabaa5dbib38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7150\/thno.11642","type":"journal-article","article-title":"Nanoparticles for radiation therapy enhancement: the key parameters","volume":"5","author":"Retif","year":"2015","journal-title":"Theranostics"},{"key":"pmbabaa5dbib39","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/j.1524-4725.2009.01276.x","type":"journal-article","article-title":"Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery report of two cases and review of the literature","volume":"35","author":"Reule","year":"2009","journal-title":"Dermatol. Surg."},{"key":"pmbabaa5dbib40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2014\/284582","type":"journal-article","article-title":"Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapy","volume":"2014","author":"Samstein","year":"2014","journal-title":"J. Skin Cancer"},{"key":"pmbabaa5dbib41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ncponc0750","type":"journal-article","article-title":"The chemoradiation paradigm in head and neck cancer","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"pmbabaa5dbib42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bcp.2010.09.022","type":"journal-article","article-title":"DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions","volume":"81","author":"Stewart","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"pmbabaa5dbib43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00405-016-4243-7","type":"journal-article","article-title":"Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck","volume":"274","author":"Strassen","year":"2017","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"pmbabaa5dbib44","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1021\/acsnano.8b07982","type":"journal-article","article-title":"Cross-correlative single-cell analysis reveals biological mechanisms of nanoparticle radiosensitization","volume":"13","author":"Turnbull","year":"2019","journal-title":"ACS Nano"},{"key":"pmbabaa5dbib45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-662-47081-7_8","type":"book","author":"Veness","year":"2016"},{"key":"pmbabaa5dbib46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/hed.20576","type":"journal-article","article-title":"Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes","volume":"29","author":"Veness","year":"2007","journal-title":"Head Neck"},{"key":"pmbabaa5dbib47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000363068","type":"journal-article","article-title":"Radiation-induced carotid artery stenosis: a comprehensive review of the literature","volume":"2","author":"Xu","year":"2014","journal-title":"Interv. Neurol."},{"key":"pmbabaa5dbib48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fonc.2018.00079","type":"journal-article","article-title":"Novel therapeutic targets in cutaneous squamous cell carcinoma","volume":"8","author":"Yanagi","year":"2018","journal-title":"Front. Oncol."}],"container-title":["Physics in Medicine &amp; Biology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d","content-type":"text\/html","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T14:29:20Z","timestamp":1765636160000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6560\/abaa5d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":48,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,11,4]]},"published-print":{"date-parts":[[2020,11,7]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6560\/abaa5d","relation":{},"ISSN":["0031-9155","1361-6560"],"issn-type":[{"value":"0031-9155","type":"print"},{"value":"1361-6560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"Thulium oxide nanoparticles as radioenhancers for the treatment of metastatic cutaneous squamous cell carcinoma","name":"article_title","label":"Article Title"},{"value":"Physics in Medicine & Biology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2020 Institute of Physics and Engineering in Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2020-07-16","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2020-07-29","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2020-11-04","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}